Castleview Partners, LLC - ATOSSA THERAPEUTICS INC ownership

ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 73 filers reported holding ATOSSA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.

Quarter-by-quarter ownership
Castleview Partners, LLC ownership history of ATOSSA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$368
-41.6%
5000.0%0.00%
-100.0%
Q2 2023$630
+74.0%
5000.0%0.00%
Q1 2023$362
+37.1%
5000.0%0.00%
Q4 2022$2645000.0%0.00%
Q3 2022$0
-100.0%
500
+502.4%
0.00%
Q2 2022$110,00083
-83.4%
0.00%
Q1 2022$0
-100.0%
500
-37.5%
0.00%
-100.0%
Q4 2021$500,000
+16566.7%
800
+60.0%
0.00%
+300.0%
Q2 2021$3,0005000.00%
Other shareholders
ATOSSA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 242,237$511,0000.10%
CVI Holdings, LLC 432,305$912,0000.06%
Virtu Financial LLC 271,937$574,0000.04%
XTX Topco Ltd 20,392$43,0000.02%
Newbridge Financial Services Group, Inc. 7,000$15,0000.01%
Renaissance Technologies 3,304,140$6,972,0000.01%
GSA CAPITAL PARTNERS LLP 22,925$48,0000.01%
Bienville Capital Management, LLC 28,379$60,0000.01%
Cutler Group LLC / CA 223,100$116,0000.01%
Royal Fund Management, LLC 15,000$31,0000.01%
View complete list of ATOSSA THERAPEUTICS INC shareholders